Incidence and Risk Factors of Hypertension Following Partial Nephrectomy in Patients With Renal Tumors: A Cross-sectional Study of Postoperative Home Blood Pressure and Antihypertensive Medications

Clin Genitourin Cancer. 2020 Oct;18(5):e619-e628. doi: 10.1016/j.clgc.2020.02.004. Epub 2020 Feb 10.

Abstract

Introduction: We aimed to evaluate the incidence and risk factors for nephrectomy-related hypertension (NR-HT) in patients with renal tumors who underwent partial nephrectomy (PN) or radical nephrectomy (RN).

Patients and methods: A retrospective cross-sectional follow-up survey of postoperative home blood pressure (BP) and defined daily dose (DDD) of antihypertensive medications was conducted in patients with renal tumors who underwent PN (210 patients) or RN (120 patients), and they were compared. We evaluated the incidence and risk factors for NR-HT, defined as the addition of antihypertensive medications in doses of 1 DDD or more after surgery, or postoperative BP of 140/90 mmHg with an increase of 20 mmHg from preoperative BP with no reduction in dose of antihypertensive medications.

Results: Both systolic (mean, 124 vs. 129 mmHg; P < .001) and diastolic BP (mean, 74 vs. 79 mmHg; P < .001) significantly increased after PN compared with RN. Systolic (P < .001) and diastolic (P = .003) BP increased significantly more after PN than after RN, and NR-HT was more frequent after PN than after RN (16% vs. 5%; P = .002). PN (odds ratio [OR], 2.93; P = .022) and higher postoperative peak C-reactive protein (OR, 2.34; P = .017) were independently associated with NR-HT. When limited to only the patients who underwent PN, acute kidney injury (OR, 2.65; P = .036) and higher postoperative peak C-reactive protein (OR, 2.54; P = .016) were independent risk factors for NR-HT.

Conclusion: PN may cause postoperative progression of hypertension possibly through renal parenchymal damage.

Keywords: Antihypertensive medication; Blood pressure; Hypertension; Partial nephrectomy; Renal tumors.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antihypertensive Agents / therapeutic use
  • Blood Pressure
  • Carcinoma, Renal Cell* / surgery
  • Cross-Sectional Studies
  • Humans
  • Hypertension* / epidemiology
  • Incidence
  • Kidney Neoplasms* / surgery
  • Nephrectomy / adverse effects
  • Retrospective Studies
  • Risk Factors

Substances

  • Antihypertensive Agents